FQ
FLGT icon

First Quadrant’s Fulgent Genetics FLGT Stock Holding History

First Quadrant’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$43K Buy
+690
New +$45.4K 0.24% 30

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Quadrant's FLGT Position: Q1 2022 in Review

First Quadrant opened a new position in Fulgent Genetics (FLGT) in Q1 2022: 690 shares worth $43K. The stake represents 0.24% of the portfolio and ranks #30 among its holdings.

275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • First Quadrant held 690 shares of Fulgent Genetics worth $43K as of Q1 2022.
  • Fulgent Genetics was a new First Quadrant position in Q1 2022.
  • Fulgent Genetics made up 0.24% of First Quadrant's portfolio in Q1 2022, its #30 holding.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.